| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 5, 2025 | Nov 6, 2025 | Nuvectis Pharma, Inc. | CEO | Buy | 56.3 | +5,000 | 0.14% | ✗ | $28.6K |
| Dec 24, 2024 | Dec 26, 2024 | Nuvectis Pharma, Inc. | CEO | Buy | 56.3 | +4,500 | 0.14% | ✗ | $20.9K |
| Nov 15, 2024 | Nov 18, 2024 | Nuvectis Pharma, Inc. | CEO | Buy | 72.5 | +20,000 | 0.62% | ✗ | $98.4K |
| May 14, 2024 | May 15, 2024 | Nuvectis Pharma, Inc. | CEO | Buy | 56.3 | +1,940 | 0.06% | ✗ | $13.1K |
| May 10, 2024 | May 13, 2024 | Nuvectis Pharma, Inc. | CEO | Buy | 56.3 | +2,000 | 0.06% | ✗ | $12.8K |
| Mar 18, 2024 | Mar 19, 2024 | Nuvectis Pharma, Inc. | CEO | Buy | 60.0 | +5,000 | 0.15% | ✗ | $51.5K |
| Oct 10, 2023 | Oct 12, 2023 | Nuvectis Pharma, Inc. | CEO | Buy | 47.5 | +640 | 0.02% | ✗ | $7.1K |
| Oct 6, 2023 | Oct 10, 2023 | Nuvectis Pharma, Inc. | CEO | Buy | 48.8 | +1,080 | 0.03% | ✗ | $12.1K |
| Oct 4, 2023 | Oct 6, 2023 | Nuvectis Pharma, Inc. | CEO | Buy | 56.3 | +3,220 | 0.10% | ✗ | $35.5K |
| Aug 15, 2023 | Aug 16, 2023 | Nuvectis Pharma, Inc. | CEO | Buy | 47.5 | +350 | 0.01% | ✗ | $5.1K |
| Aug 8, 2023 | Aug 11, 2023 | Nuvectis Pharma, Inc. | CEO | Buy | 47.5 | +300 | 0.01% | ✗ | $4.4K |
| Jul 20, 2023 | Jul 24, 2023 | Nuvectis Pharma, Inc. | CEO | Buy | 47.5 | +335 | 0.01% | ✗ | $5K |
| Jul 19, 2023 | Jul 20, 2023 | Nuvectis Pharma, Inc. | CEO | Buy | 47.5 | +200 | 0.01% | ✗ | $2.9K |
| Jul 7, 2023 | Jul 18, 2023 | Nuvectis Pharma, Inc. | CEO | Buy | 47.5 | +260 | 0.01% | ✗ | $4K |
| Jul 6, 2023 | Jul 7, 2023 | Nuvectis Pharma, Inc. | CEO | Buy | 47.5 | +320 | 0.01% | ✗ | $4.8K |
| Jun 26, 2023 | Jun 27, 2023 | Nuvectis Pharma, Inc. | CEO | Buy | 48.8 | +750 | 0.02% | ✗ | $12.4K |
| Jun 21, 2023 | Jun 22, 2023 | Nuvectis Pharma, Inc. | CEO | Buy | 47.5 | +500 | 0.02% | ✗ | $8.9K |
| Jun 7, 2023 | Jun 8, 2023 | Nuvectis Pharma, Inc. | CEO | Buy | 47.5 | +350 | 0.01% | ✗ | $6.1K |
| May 31, 2023 | Jun 1, 2023 | Nuvectis Pharma, Inc. | CEO | Buy | 47.5 | +330 | 0.01% | ✗ | $5.7K |
| May 24, 2023 | May 26, 2023 | Nuvectis Pharma, Inc. | CEO | Buy | 47.5 | +200 | 0.01% | ✗ | $3.5K |
| May 16, 2023 | May 18, 2023 | Nuvectis Pharma, Inc. | CEO | Buy | 47.5 | +320 | 0.01% | ✗ | $5.4K |
| Mar 23, 2023 | Mar 27, 2023 | Nuvectis Pharma, Inc. | CEO | Buy | 47.5 | +230 | 0.01% | ✗ | $2.8K |
| Mar 21, 2023 | Mar 23, 2023 | Nuvectis Pharma, Inc. | CEO | Buy | 47.5 | +480 | 0.01% | ✗ | $5.8K |
| Mar 20, 2023 | Mar 21, 2023 | Beyond Air, Inc. | Director | Buy | 78.8 | +2,300 | 1.61% | ✗ | $14.9K |
| Mar 14, 2023 | Mar 16, 2023 | Nuvectis Pharma, Inc. | CEO | Buy | 56.3 | +2,160 | 0.07% | ✗ | $23.5K |
| Nov 30, 2022 | Nov 30, 2022 | Nuvectis Pharma, Inc. | CEO | Buy | 47.5 | +150 | 0.00% | ✗ | $1.1K |
| Nov 25, 2022 | Nov 29, 2022 | Nuvectis Pharma, Inc. | CEO | Buy | 47.5 | +450 | 0.01% | ✗ | $3.3K |
| Nov 17, 2022 | Nov 21, 2022 | Nuvectis Pharma, Inc. | CEO | Buy | 47.5 | +750 | 0.02% | ✗ | $5.4K |
| Nov 10, 2022 | Nov 16, 2022 | Nuvectis Pharma, Inc. | CEO | Buy | 47.5 | +1,000 | 0.03% | ✗ | $7.1K |
| Sep 28, 2022 | Oct 3, 2022 | Nuvectis Pharma, Inc. | CEO | Buy | 47.5 | +1,000 | 0.03% | ✗ | $7.3K |
| Sep 23, 2022 | Sep 27, 2022 | Nuvectis Pharma, Inc. | CEO | Buy | 48.8 | +1,500 | 0.05% | ✗ | $11.8K |
| Sep 1, 2022 | Sep 6, 2022 | Nuvectis Pharma, Inc. | CEO | Buy | 56.3 | +1,700 | 0.06% | ✗ | $14.1K |
| Aug 23, 2022 | Aug 30, 2022 | Nuvectis Pharma, Inc. | CEO | Buy | 48.8 | +1,500 | 0.05% | ✗ | $13.6K |
| Aug 18, 2022 | Aug 22, 2022 | Nuvectis Pharma, Inc. | CEO | Buy | 72.5 | +19,426 | 0.65% | ✗ | $168.7K |
| Aug 11, 2022 | Aug 16, 2022 | Nuvectis Pharma, Inc. | CEO | Buy | 72.5 | +19,669 | 0.66% | ✗ | $165.2K |
| Jun 30, 2022 | Jul 5, 2022 | Beyond Air, Inc. | Director | Sell | 20.0 | -40,000 | -21.93% | ✗ | $261.1K |
| Jun 28, 2022 | Jun 30, 2022 | Nuvectis Pharma, Inc. | CEO | Buy | 56.3 | +4,000 | 0.13% | ✗ | $46.5K |
| Jun 22, 2022 | Jun 27, 2022 | Nuvectis Pharma, Inc. | CEO | Buy | 47.5 | +700 | 0.02% | ✗ | $8.5K |
| May 26, 2022 | May 31, 2022 | Nuvectis Pharma, Inc. | CEO | Buy | 48.8 | +1,000 | 0.03% | ✗ | $15.8K |
| May 19, 2022 | May 23, 2022 | Nuvectis Pharma, Inc. | CEO | Buy | 48.8 | +1,200 | 0.04% | ✗ | $20.1K |
| May 17, 2022 | May 19, 2022 | Nuvectis Pharma, Inc. | CEO | Buy | 56.3 | +2,010 | 0.07% | ✗ | $39.2K |
| May 13, 2022 | May 17, 2022 | Nuvectis Pharma, Inc. | CEO | Buy | 56.3 | +1,700 | 0.06% | ✗ | $32K |
| May 12, 2022 | May 13, 2022 | Nuvectis Pharma, Inc. | CEO | Buy | 65.0 | +12,245 | 0.42% | ✗ | $208K |
| Mar 28, 2022 | Mar 29, 2022 | Nuvectis Pharma, Inc. | CEO | Buy | 56.3 | +4,000 | 0.14% | ✗ | $28.2K |
| Mar 17, 2022 | Mar 18, 2022 | Nuvectis Pharma, Inc. | CEO | Buy | 65.0 | +7,000 | 0.25% | ✗ | $53.4K |
| Feb 14, 2022 | Feb 15, 2022 | Nuvectis Pharma, Inc. | CEO | Buy | 61.3 | +8,000 | 0.29% | ✗ | $47K |
| Feb 10, 2022 | Feb 11, 2022 | Nuvectis Pharma, Inc. | CEO | Buy | 65.0 | +8,500 | 0.30% | ✗ | $53.9K |
| Feb 4, 2022 | Feb 8, 2022 | Nuvectis Pharma, Inc. | CEO | Buy | 95.0 | +232,500 | 9.06% | ✗ | $1.2M |
| Nov 24, 2021 | Nov 26, 2021 | Beyond Air, Inc. | Director | Sell | 20.0 | -37,464 | -17.04% | ✗ | $507.1K |
| Nov 22, 2021 | Nov 24, 2021 | Beyond Air, Inc. | Director | Sell | 22.5 | -12,536 | -5.39% | ✗ | $183K |
| Feb 11, 2021 | Feb 18, 2021 | Beyond Air, Inc. | Director | Sell | 22.5 | -24,919 | -6.39% | ✗ | $158.4K |
| Jan 2, 2021 | Feb 8, 2021 | Beyond Air, Inc. | Director | Sell | 26.3 | -5,700 | -3.01% | ✗ | $33.6K |
| Aug 25, 2020 | Aug 27, 2020 | Beyond Air, Inc. | Director | Sell | 52.5 | -1,580 | -0.83% | ✓ | $9.4K |
| Aug 21, 2020 | Aug 25, 2020 | Beyond Air, Inc. | Director | Sell | 41.3 | -7,135 | -3.60% | ✓ | $41.8K |
| Aug 19, 2020 | Aug 21, 2020 | Beyond Air, Inc. | Director | Sell | 37.5 | -10,311 | -4.94% | ✓ | $65K |
| Aug 18, 2020 | Aug 19, 2020 | Beyond Air, Inc. | Director | Sell | 45.0 | -4,578 | -2.15% | ✓ | $26.7K |
| Aug 17, 2020 | Aug 18, 2020 | Beyond Air, Inc. | Director | Sell | 45.0 | -4,413 | -2.03% | ✓ | $25.2K |
| Aug 14, 2020 | Aug 17, 2020 | Beyond Air, Inc. | Director | Sell | 45.0 | -6,680 | -2.98% | ✓ | $36.9K |
| Aug 13, 2020 | Aug 14, 2020 | Beyond Air, Inc. | Director | Sell | 48.8 | -4,088 | -1.79% | ✓ | $22.5K |
| Aug 12, 2020 | Aug 13, 2020 | Beyond Air, Inc. | Director | Sell | 45.0 | -4,689 | -2.01% | ✓ | $24.8K |
| Aug 10, 2020 | Aug 12, 2020 | Beyond Air, Inc. | Director | Sell | 41.3 | -7,347 | -3.06% | ✓ | $40.2K |
| Jul 27, 2020 | Aug 12, 2020 | Beyond Air, Inc. | Director | Sell | 48.8 | -4,917 | -1.73% | ✓ | $30.8K |
| Aug 7, 2020 | Aug 10, 2020 | Beyond Air, Inc. | Director | Sell | 37.5 | -10,222 | -4.00% | ✓ | $54.7K |
| Aug 5, 2020 | Aug 7, 2020 | Beyond Air, Inc. | Director | Sell | 37.5 | -9,811 | -3.70% | ✓ | $59.1K |
| Aug 4, 2020 | Aug 6, 2020 | Beyond Air, Inc. | Director | Sell | 48.8 | -3,649 | -1.36% | ✓ | $22.4K |
| Jul 31, 2020 | Aug 4, 2020 | Beyond Air, Inc. | Director | Sell | 45.0 | -6,682 | -2.42% | ✓ | $41.5K |
| Jul 29, 2020 | Jul 31, 2020 | Beyond Air, Inc. | Director | Sell | 45.0 | -7,761 | -2.74% | ✓ | $48.1K |
| Aug 21, 2007 | Aug 21, 2007 | XTL BIOPHARMACEUTICALS LTD | CEO | Buy | 91.3 | +15,279 | 316.86% | ✗ | $19.9K |
| Aug 25, 2006 | Aug 28, 2006 | XTL BIOPHARMACEUTICALS LTD | CEO | Buy | 90.0 | +1,600 | 49.66% | ✗ | $4.8K |